Wellington Management Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-75,161
Closed -$247K 1950
2024
Q2
$247K Buy
75,161
+30,976
+70% +$136K ﹤0.01% 1845
2024
Q1
$324K Buy
+44,185
New +$273K ﹤0.01% 1846
2022
Q4
Sell
-568,382
Closed -$12.7M 2031
2022
Q3
$12.7M Sell
568,382
-22,297
-4% -$644K ﹤0.01% 1035
2022
Q2
$14.6M Sell
590,679
-140,446
-19% -$3.88M ﹤0.01% 1027
2022
Q1
$28.3M Buy
731,125
+31,373
+4% +$1.21M ﹤0.01% 936
2021
Q4
$40.9M Buy
699,752
+89,212
+15% +$5.06M 0.01% 891
2021
Q3
$36.2M Buy
610,540
+359,535
+143% +$28.2M 0.01% 918
2021
Q2
$21.8M Buy
251,005
+70,557
+39% +$5.69M ﹤0.01% 1076
2021
Q1
$14.9M Sell
180,448
-13,797
-7% -$1.32M ﹤0.01% 1139
2020
Q4
$17.7M Buy
+194,245
New +$12.1M ﹤0.01% 1066
2020
Q1
Sell
-39,006
Closed -$764K 1957
2019
Q4
$764K Buy
+39,006
New +$619K ﹤0.01% 1771
2016
Q1
Sell
-1,306,569
Closed -$4.4M 2154
2015
Q4
$4.4M Sell
1,306,569
-155,953
-11% -$655K ﹤0.01% 1402
2015
Q3
$7.8M Sell
1,462,522
-37,126
-2% -$254K ﹤0.01% 1245
2015
Q2
$9.7M Buy
1,499,648
+41,950
+3% +$251K ﹤0.01% 1235
2015
Q1
$7.13M Buy
1,457,698
+36,770
+3% +$182K ﹤0.01% 1347
2014
Q4
$7.15M Buy
1,420,928
+1,953
+0.1% +$8.62K ﹤0.01% 1334
2014
Q3
$7.29M Buy
1,418,975
+224,965
+19% +$1.3M ﹤0.01% 1331
2014
Q2
$7.53M Buy
1,194,010
+72,830
+6% +$513K ﹤0.01% 1332
2014
Q1
$10.9M Sell
1,121,180
-76,020
-6% -$587K ﹤0.01% 1215
2013
Q4
$7.52M Buy
+1,197,200
New +$7.54M ﹤0.01% 1338

Other funds holding FATE